Page 2 - Oppenheimer Rare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oppenheimer rare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oppenheimer Rare Today - Breaking & Trending Today

Rezolute to Present at the Oppenheimer Rare and Orphan Disease Summit

Published: May 17, 2021
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE)
Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing novel therapies for diseases caused by chronic glucose imbalance, today announced that management will present at the Oppenheimer Rare and Orphan Disease Summit. The presentation will be available on-demand starting at 8:00 AM ET on Friday, May 21, 2021.
A webcast of the presentation will be available for 90 days on the “IR Calendar” page within the Investors section of the Rezolute website at https://ir.rezolutebio.com/ir-calendar.
About Rezolute, Inc.
Rezolute is advancing novel therapies for diseases caused by chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in Phase 2b development for treatment of congenital hyperinsulinism (CHI), a rare pediatric endocrine disorder. The Company is also developing RZ402, an orally available plasma kallikrein inhibitor, for the tr ....

Rezolute Inc , Securities Exchange , Oppenheimer Rare , Orphan Disease , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , பத்திரங்கள் பரிமாற்றம் , ஆர்ஃபந் நோய் , பத்திரங்கள் நாடகம் , பத்திரங்கள் பரிமாற்றம் நாடகம் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

Best Penny Stocks to Buy on Robinhood Right Now? 4 To Check Out

Best Penny Stocks to Buy on Robinhood Right Now? 4 To Check Out
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

Remy Luthringer , Johnp Butler , Corbus Pharmaceuticals Holdings Do , National Institute Of Allergy , Drug Administration For Vadadustat , Corbus Pharmaceuticals Holdings Inc , Akebia Therapeutics Inc , Otsuka Pharmaceutical Co , Minerva Neurosciences Inc , Meten Edtechx Education Group Ltd , Are These , Penny Stocks Ready , Stocks To Watch As Dogecoin , Penny Stocks , Pharmaceuticals Holdings , Edtechx Education Group , Corbus Pharmaceuticals Holdings , Markets Global Healthcare Conference , Oppenheimer Rare , Orphan Disease Summit , Jefferies Virtual Global Healthcare , National Institute , Infectious Diseases , Executive Chairman , New Drug Application , Drug Administration ,

Best Penny Stocks to Buy on Robinhood Right Now? 4 To Check Out | FinancialContent Business Page

FinancialContent fully hosted finance channel ....

Remy Luthringer , Johnp Butler , Corbus Pharmaceuticals Holdings Do , National Institute Of Allergy , Drug Administration For Vadadustat , Corbus Pharmaceuticals Holdings Inc , Akebia Therapeutics Inc , Otsuka Pharmaceutical Co , Minerva Neurosciences Inc , Meten Edtechx Education Group Ltd , Are These , Penny Stocks Ready , Stocks To Watch As Dogecoin , Penny Stocks , Pharmaceuticals Holdings , Edtechx Education Group , Corbus Pharmaceuticals Holdings , Markets Global Healthcare Conference , Oppenheimer Rare , Orphan Disease Summit , Jefferies Virtual Global Healthcare , National Institute , Infectious Diseases , Executive Chairman , New Drug Application , Drug Administration ,

Viridian Therapeutics to Participate in Upcoming Investor Conferences

BOULDER, Colo., May 14, 2021 (GLOBE NEWSWIRE) Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biopharmaceutical company advancing new treatments for . ....

United States , Darby Pearson , Verge Scientific Communications , Viridian Therapeutics Inc , Jonathan Violin , Chief Executive Officer , Oppenheimer Rare , Orphan Disease Summit , Jefferies Virtual Healthcare , Chat Time , Viridian Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , டார்பி பியர்சன் , விளிம்பு அறிவியல் தகவல்தொடர்புகள் , விரிடியன் சிகிச்சை இன்க் , ஜொனாதன் வயலின் , தலைமை நிர்வாகி அதிகாரி , ஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் , விரிடியன் சிகிச்சை ,

Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit

Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit
News provided by
Share this article
SAN DIEGO, May 14, 2021 /PRNewswire/
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ( Regulus ), today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 11:35 A.M. ET.
A live webcast of the presentation will be available on the investor relations section of the Company s website at www.regulusrx.com. A replay of the webcast will be archived for 30 days following the presentation date. ....

San Diego , United States , Jay Hagan , Exchange Commission , Regulus Therapeutics Inc , Chief Executive Officer , Oppenheimer Rare , Orphan Disease Summit , Private Securities Litigation Reform Act , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , ஜெய் ஹகன் , பரிமாற்றம் தரகு , ஒழுங்குமுறை சிகிச்சை இன்க் , தலைமை நிர்வாகி அதிகாரி , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,